Stephane Piat - Carmat SA CEO Director

All Insiders . Germany . 
Stock . Carmat SA . Stakeholders . Insider . Stephane Piat
CXT Stock  EUR 1.00  0.02  2.04%   

Insider

Stephane Piat is CEO Director of Carmat SA
Age 52
Phone33 1 39 45 64 50
Webhttps://www.carmatsa.com

Carmat SA Management Efficiency

The company has return on total asset (ROA) of (0.3856) % which means that it has lost $0.3856 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (2.5378) %, meaning that it generated substantial loss on money invested by shareholders. Carmat SA's management efficiency ratios could be used to measure how well Carmat SA manages its routine affairs as well as how well it operates its assets and liabilities.
Carmat SA has accumulated 51.89 M in total debt with debt to equity ratio (D/E) of 4.98, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Carmat SA has a current ratio of 4.14, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Carmat SA until it has trouble settling it off, either with new capital or with free cash flow. So, Carmat SA's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Carmat SA sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Carmat to invest in growth at high rates of return. When we think about Carmat SA's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Julian NikolchevIntuitive Surgical
69
Gary LoebIntuitive Surgical
N/A
Rene FaberSartorius Aktiengesellschaft
48
David RosaIntuitive Surgical
55
Gary GuthartIntuitive Surgical
57
AM AMResMed Inc
80
Mei WangSartorius Aktiengesellschaft
N/A
Constance BienfaitResmed Inc DRC
N/A
Robert DeSantisIntuitive Surgical
57
Vered KeisarResmed Inc DRC
N/A
Robert DouglasResmed Inc DRC
63
Robert DouglasResMed Inc
63
Heiko ImhlSartorius Stedim Biotech
N/A
Patricia SpannagelSartorius Aktiengesellschaft
N/A
Ariel BauerEssilorLuxottica Socit anonyme
N/A
AM AMResmed Inc DRC
80
Amelie ButonSartorius Stedim Biotech
32
Vered KeisarResMed Inc
N/A
Brett SandercockResMed Inc
56
David PendarvisResMed Inc
64
Giorgio IannellaEssilorLuxottica Socit anonyme
N/A
Carmat SA designs and develops total artificial heart for people suffering from end-stage biventricular heart failure in France and internationally. The company was founded in 2008 and is based in Vlizy-Villacoublay, France. CARMAT EO operates under Medical Instruments Supplies classification in Germany and is traded on Frankfurt Stock Exchange. It employs 119 people. Carmat SA (CXT) is traded on Frankfurt Exchange in Germany and employs 171 people.

Management Performance

Return On Equity-2.54
Return On Asset-0.39

Carmat SA Leadership Team

Elected by the shareholders, the Carmat SA's board of directors comprises two types of representatives: Carmat SA inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Carmat. The board's role is to monitor Carmat SA's management team and ensure that shareholders' interests are well served. Carmat SA's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Carmat SA's outside directors are responsible for providing unbiased perspectives on the board's policies.
Francesco Arecchi, Marketing Mang
Petrus Jansen, Chief Officer
Eric Richez, Sales Director
Stephane Piat, CEO Director
Raouia Bouyanzer, HR Director
Pascale dArbonneau, CFO relations

Carmat Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Carmat SA a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity-2.54
Return On Asset-0.39
Operating Margin(21.94) %
Current Valuation213.74 M
Shares Outstanding22.67 M
Shares Owned By Insiders42.90 %
Shares Owned By Institutions2.28 %
Price To Earning(5.82) X
Price To Book1,194 X
Price To Sales87.53 X

Currently Active Assets on Macroaxis

CCitigroup
GMGeneral Motors
FFord Motor
GMGeneral Motors
VVisa Class A

Other Information on Investing in Carmat Stock

Carmat SA financial ratios help investors to determine whether Carmat Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Carmat with respect to the benefits of owning Carmat SA security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY